General Information of Drug Transporter (DT)
DT ID DTD0463 Transporter Info
Gene Name SLC7A10
Transporter Name Asc-type amino acid transporter 1
Gene ID
56301
UniProt ID
Q9NS82
Epigenetic Regulations of This DT (EGR)

Methylation

  Hepatocellular carcinoma

         13 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

5'UTR (cg06501084)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.54E+00 Statistic Test p-value:3.11E-14; Z-score:-2.13E+00

Methylation in Case

4.46E-01 (Median) Methylation in Control 6.85E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg18074184)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.31E+00 Statistic Test p-value:2.37E-16; Z-score:3.40E+00

Methylation in Case

6.58E-01 (Median) Methylation in Control 5.03E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg25308885)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.44E+00 Statistic Test p-value:7.78E-07; Z-score:1.93E+00

Methylation in Case

1.93E-01 (Median) Methylation in Control 1.34E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg02824451)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.45E+00 Statistic Test p-value:1.08E-06; Z-score:1.09E+00

Methylation in Case

7.37E-02 (Median) Methylation in Control 5.08E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg00910067)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.05E+00 Statistic Test p-value:1.89E-02; Z-score:3.97E-01

Methylation in Case

2.56E-01 (Median) Methylation in Control 2.43E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg18336281)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.07E+00 Statistic Test p-value:2.12E-02; Z-score:4.49E-01

Methylation in Case

2.39E-01 (Median) Methylation in Control 2.23E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

TSS200 (cg03523434)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.47E+00 Statistic Test p-value:8.13E-18; Z-score:-3.81E+00

Methylation in Case

4.82E-01 (Median) Methylation in Control 7.09E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

TSS200 (cg13272818)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.17E+00 Statistic Test p-value:9.37E-05; Z-score:1.05E+00

Methylation in Case

4.34E-01 (Median) Methylation in Control 3.71E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

Body (cg11902539)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.73E+00 Statistic Test p-value:1.85E-18; Z-score:-8.32E+00

Methylation in Case

5.16E-01 (Median) Methylation in Control 8.91E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

Body (cg25945642)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.38E+00 Statistic Test p-value:8.59E-11; Z-score:-1.84E+00

Methylation in Case

4.98E-01 (Median) Methylation in Control 6.87E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon11

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

Body (cg03049846)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.12E+00 Statistic Test p-value:2.12E-08; Z-score:-1.38E+00

Methylation in Case

6.27E-01 (Median) Methylation in Control 7.01E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon12

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

Body (cg04305036)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.09E+00 Statistic Test p-value:1.97E-05; Z-score:-1.02E+00

Methylation in Case

5.36E-01 (Median) Methylation in Control 5.87E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon13

Methylation of SLC7A10 in hepatocellular carcinoma [ 1 ]

Location

Body (cg09968457)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:3.77E-05; Z-score:-6.71E-01

Methylation in Case

8.09E-01 (Median) Methylation in Control 8.29E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in pancretic ductal adenocarcinoma [ 2 ]

Location

5'UTR (cg26779716)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.30E+00 Statistic Test p-value:6.79E-14; Z-score:1.21E+00

Methylation in Case

1.10E-01 (Median) Methylation in Control 8.44E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in pancretic ductal adenocarcinoma [ 2 ]

Location

TSS200 (cg22639895)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.29E+00 Statistic Test p-value:1.14E-12; Z-score:9.60E-01

Methylation in Case

6.91E-02 (Median) Methylation in Control 5.35E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg00445475)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.40E+00 Statistic Test p-value:3.34E-09; Z-score:1.52E+00

Methylation in Case

4.13E-01 (Median) Methylation in Control 2.95E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg06728970)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.08E+00 Statistic Test p-value:1.05E-04; Z-score:-8.02E-01

Methylation in Case

5.37E-01 (Median) Methylation in Control 5.82E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC7A10 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg02501410)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.05E+00 Statistic Test p-value:5.11E-04; Z-score:-8.39E-01

Methylation in Case

7.38E-01 (Median) Methylation in Control 7.76E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC7A10 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg01454305)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:3.06E-02; Z-score:-1.99E-01

Methylation in Case

7.98E-01 (Median) Methylation in Control 8.11E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Bladder cancer

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in bladder cancer [ 3 ]

Location

TSS1500 (cg23331484)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.94E+00 Statistic Test p-value:1.90E-08; Z-score:7.97E+00

Methylation in Case

5.62E-01 (Median) Methylation in Control 2.90E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in bladder cancer [ 3 ]

Location

TSS1500 (cg02824451)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.29E+00 Statistic Test p-value:2.59E-02; Z-score:2.98E+00

Methylation in Case

4.65E-02 (Median) Methylation in Control 3.61E-02 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in bladder cancer [ 3 ]

Location

Body (cg03049846)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-2.27E+00 Statistic Test p-value:5.30E-09; Z-score:-7.69E+00

Methylation in Case

2.66E-01 (Median) Methylation in Control 6.03E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in bladder cancer [ 3 ]

Location

Body (cg09968457)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.16E+00 Statistic Test p-value:3.93E-06; Z-score:-5.79E+00

Methylation in Case

6.87E-01 (Median) Methylation in Control 7.96E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC7A10 in bladder cancer [ 3 ]

Location

Body (cg04305036)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.35E+00 Statistic Test p-value:5.55E-05; Z-score:-1.49E+01

Methylation in Case

3.77E-01 (Median) Methylation in Control 5.07E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC7A10 in bladder cancer [ 3 ]

Location

Body (cg18031850)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.52E+00 Statistic Test p-value:4.53E-03; Z-score:2.67E+00

Methylation in Case

2.22E-01 (Median) Methylation in Control 1.46E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Breast cancer

           9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in breast cancer [ 4 ]

Location

TSS1500 (cg23331484)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.84E+00 Statistic Test p-value:5.01E-13; Z-score:2.42E+00

Methylation in Case

3.87E-01 (Median) Methylation in Control 2.10E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in breast cancer [ 4 ]

Location

TSS1500 (cg18336281)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.19E+00 Statistic Test p-value:1.82E-06; Z-score:1.28E+00

Methylation in Case

1.72E-01 (Median) Methylation in Control 1.44E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in breast cancer [ 4 ]

Location

TSS1500 (cg25308885)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.13E+00 Statistic Test p-value:1.45E-03; Z-score:5.47E-01

Methylation in Case

1.43E-01 (Median) Methylation in Control 1.26E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in breast cancer [ 4 ]

Location

TSS1500 (cg00910067)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.09E+00 Statistic Test p-value:3.47E-03; Z-score:6.73E-01

Methylation in Case

1.85E-01 (Median) Methylation in Control 1.70E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC7A10 in breast cancer [ 4 ]

Location

TSS200 (cg13272818)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.25E+00 Statistic Test p-value:5.24E-08; Z-score:2.89E+00

Methylation in Case

3.11E-01 (Median) Methylation in Control 2.49E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC7A10 in breast cancer [ 4 ]

Location

Body (cg18031850)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:2.05E+00 Statistic Test p-value:1.09E-17; Z-score:3.60E+00

Methylation in Case

3.55E-01 (Median) Methylation in Control 1.73E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC7A10 in breast cancer [ 4 ]

Location

Body (cg05976074)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.23E+00 Statistic Test p-value:1.71E-11; Z-score:2.15E+00

Methylation in Case

3.80E-01 (Median) Methylation in Control 3.09E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC7A10 in breast cancer [ 4 ]

Location

Body (cg25543755)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.17E+00 Statistic Test p-value:8.87E-07; Z-score:9.48E-01

Methylation in Case

5.96E-01 (Median) Methylation in Control 5.09E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC7A10 in breast cancer [ 4 ]

Location

Body (cg04305036)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.10E+00 Statistic Test p-value:1.20E-05; Z-score:-1.44E+00

Methylation in Case

4.86E-01 (Median) Methylation in Control 5.33E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg23331484)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:2.51E+00 Statistic Test p-value:1.23E-11; Z-score:3.20E+00

Methylation in Case

3.66E-01 (Median) Methylation in Control 1.46E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg00910067)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.90E+00 Statistic Test p-value:4.98E-08; Z-score:4.09E+00

Methylation in Case

3.86E-01 (Median) Methylation in Control 2.03E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg25308885)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.27E+00 Statistic Test p-value:3.02E-05; Z-score:1.31E+00

Methylation in Case

1.48E-01 (Median) Methylation in Control 1.17E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg18336281)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.30E+00 Statistic Test p-value:1.10E-04; Z-score:1.68E+00

Methylation in Case

1.99E-01 (Median) Methylation in Control 1.53E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC7A10 in clear cell renal cell carcinoma [ 5 ]

Location

TSS1500 (cg02824451)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.09E+00 Statistic Test p-value:1.93E-02; Z-score:4.37E-01

Methylation in Case

2.70E-02 (Median) Methylation in Control 2.47E-02 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC7A10 in clear cell renal cell carcinoma [ 5 ]

Location

Body (cg18031850)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.87E+00 Statistic Test p-value:3.50E-06; Z-score:2.45E+00

Methylation in Case

1.70E-01 (Median) Methylation in Control 9.11E-02 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC7A10 in clear cell renal cell carcinoma [ 5 ]

Location

Body (cg05976074)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.42E+00 Statistic Test p-value:1.13E-05; Z-score:2.41E+00

Methylation in Case

3.60E-01 (Median) Methylation in Control 2.53E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC7A10 in clear cell renal cell carcinoma [ 5 ]

Location

Body (cg25543755)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.15E+00 Statistic Test p-value:3.58E-03; Z-score:1.21E+00

Methylation in Case

4.60E-01 (Median) Methylation in Control 4.02E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Colon cancer

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in colon adenocarcinoma [ 6 ]

Location

TSS1500 (cg20982412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:2.08E+00 Statistic Test p-value:3.11E-07; Z-score:8.09E+00

Methylation in Case

5.27E-01 (Median) Methylation in Control 2.54E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in colon adenocarcinoma [ 6 ]

Location

TSS1500 (cg05863502)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.13E+00 Statistic Test p-value:1.54E-05; Z-score:9.62E-01

Methylation in Case

7.02E-01 (Median) Methylation in Control 6.20E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in colon adenocarcinoma [ 6 ]

Location

TSS1500 (cg07646731)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.50E+00 Statistic Test p-value:5.90E-04; Z-score:2.56E+00

Methylation in Case

2.28E-01 (Median) Methylation in Control 1.52E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in colon adenocarcinoma [ 6 ]

Location

TSS200 (cg14613271)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:2.16E+00 Statistic Test p-value:7.81E-06; Z-score:3.32E+00

Methylation in Case

6.09E-01 (Median) Methylation in Control 2.82E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC7A10 in colon adenocarcinoma [ 6 ]

Location

TSS200 (cg04633600)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.68E+00 Statistic Test p-value:2.85E-03; Z-score:2.96E+00

Methylation in Case

9.21E-02 (Median) Methylation in Control 5.48E-02 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC7A10 in colon adenocarcinoma [ 6 ]

Location

1stExon (cg02318629)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:4.00E+00 Statistic Test p-value:1.26E-08; Z-score:1.32E+01

Methylation in Case

5.40E-01 (Median) Methylation in Control 1.35E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC7A10 in colon adenocarcinoma [ 6 ]

Location

1stExon (cg08022436)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.60E+00 Statistic Test p-value:3.21E-06; Z-score:3.53E+00

Methylation in Case

4.46E-01 (Median) Methylation in Control 2.78E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC7A10 in colon adenocarcinoma [ 6 ]

Location

Body (cg00662647)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:4.74E+00 Statistic Test p-value:3.27E-05; Z-score:1.28E+01

Methylation in Case

4.16E-01 (Median) Methylation in Control 8.77E-02 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Colorectal cancer

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in colorectal cancer [ 7 ]

Location

TSS1500 (cg23331484)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.48E+00 Statistic Test p-value:2.38E-05; Z-score:1.32E+00

Methylation in Case

3.39E-01 (Median) Methylation in Control 2.30E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in colorectal cancer [ 7 ]

Location

TSS1500 (cg02824451)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:1.21E-03; Z-score:-4.42E-02

Methylation in Case

3.48E-02 (Median) Methylation in Control 3.54E-02 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in colorectal cancer [ 7 ]

Location

TSS1500 (cg25308885)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.03E+00 Statistic Test p-value:4.88E-03; Z-score:9.08E-02

Methylation in Case

9.52E-02 (Median) Methylation in Control 9.25E-02 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in colorectal cancer [ 7 ]

Location

TSS1500 (cg18336281)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.06E+00 Statistic Test p-value:1.98E-02; Z-score:3.86E-01

Methylation in Case

2.18E-01 (Median) Methylation in Control 2.05E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC7A10 in colorectal cancer [ 7 ]

Location

TSS200 (cg13272818)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.11E+00 Statistic Test p-value:4.17E-04; Z-score:8.78E-01

Methylation in Case

4.20E-01 (Median) Methylation in Control 3.79E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC7A10 in colorectal cancer [ 7 ]

Location

Body (cg03049846)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.26E+00 Statistic Test p-value:5.45E-14; Z-score:-5.10E+00

Methylation in Case

6.33E-01 (Median) Methylation in Control 7.95E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC7A10 in colorectal cancer [ 7 ]

Location

Body (cg04305036)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.14E+00 Statistic Test p-value:1.24E-10; Z-score:-2.22E+00

Methylation in Case

6.18E-01 (Median) Methylation in Control 7.06E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC7A10 in colorectal cancer [ 7 ]

Location

Body (cg18031850)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:2.06E+00 Statistic Test p-value:5.42E-09; Z-score:2.88E+00

Methylation in Case

2.35E-01 (Median) Methylation in Control 1.14E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC7A10 in colorectal cancer [ 7 ]

Location

Body (cg09968457)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:1.30E-03; Z-score:-1.22E+00

Methylation in Case

8.90E-01 (Median) Methylation in Control 9.10E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC7A10 in colorectal cancer [ 7 ]

Location

Body (cg05976074)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.05E+00 Statistic Test p-value:3.50E-02; Z-score:5.33E-01

Methylation in Case

5.64E-01 (Median) Methylation in Control 5.38E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  HIV infection

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in HIV infection [ 8 ]

Location

TSS1500 (cg23331484)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.45E+00 Statistic Test p-value:1.14E-09; Z-score:2.49E+00

Methylation in Case

4.54E-01 (Median) Methylation in Control 3.14E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in HIV infection [ 8 ]

Location

TSS1500 (cg25308885)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.36E+00 Statistic Test p-value:3.45E-05; Z-score:1.87E+00

Methylation in Case

1.58E-01 (Median) Methylation in Control 1.16E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in HIV infection [ 8 ]

Location

TSS1500 (cg00910067)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.19E+00 Statistic Test p-value:2.91E-04; Z-score:1.02E+00

Methylation in Case

2.14E-01 (Median) Methylation in Control 1.80E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in HIV infection [ 8 ]

Location

TSS1500 (cg02824451)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.22E+00 Statistic Test p-value:6.78E-04; Z-score:8.31E-01

Methylation in Case

6.24E-02 (Median) Methylation in Control 5.12E-02 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC7A10 in HIV infection [ 8 ]

Location

TSS1500 (cg18336281)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.15E+00 Statistic Test p-value:4.17E-03; Z-score:9.98E-01

Methylation in Case

1.96E-01 (Median) Methylation in Control 1.70E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC7A10 in HIV infection [ 8 ]

Location

TSS200 (cg13272818)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.17E+00 Statistic Test p-value:9.10E-04; Z-score:1.32E+00

Methylation in Case

3.19E-01 (Median) Methylation in Control 2.74E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC7A10 in HIV infection [ 8 ]

Location

Body (cg18031850)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.38E+00 Statistic Test p-value:1.98E-05; Z-score:1.91E+00

Methylation in Case

2.77E-01 (Median) Methylation in Control 2.00E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC7A10 in HIV infection [ 8 ]

Location

Body (cg04305036)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.08E+00 Statistic Test p-value:3.92E-04; Z-score:-1.39E+00

Methylation in Case

6.82E-01 (Median) Methylation in Control 7.34E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC7A10 in HIV infection [ 8 ]

Location

Body (cg03049846)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.04E+00 Statistic Test p-value:6.91E-04; Z-score:-1.12E+00

Methylation in Case

8.28E-01 (Median) Methylation in Control 8.62E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC7A10 in HIV infection [ 8 ]

Location

Body (cg05976074)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.06E+00 Statistic Test p-value:1.38E-02; Z-score:6.26E-01

Methylation in Case

4.69E-01 (Median) Methylation in Control 4.41E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in lung adenocarcinoma [ 9 ]

Location

TSS1500 (cg23331484)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.39E+00 Statistic Test p-value:1.35E-04; Z-score:3.42E+00

Methylation in Case

4.36E-01 (Median) Methylation in Control 3.14E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in lung adenocarcinoma [ 9 ]

Location

TSS1500 (cg02824451)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.60E+00 Statistic Test p-value:4.66E-03; Z-score:2.83E+00

Methylation in Case

1.11E-01 (Median) Methylation in Control 6.96E-02 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in lung adenocarcinoma [ 9 ]

Location

TSS1500 (cg00910067)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.29E+00 Statistic Test p-value:1.37E-02; Z-score:1.96E+00

Methylation in Case

3.19E-01 (Median) Methylation in Control 2.47E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in lung adenocarcinoma [ 9 ]

Location

TSS200 (cg13272818)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.18E+00 Statistic Test p-value:3.70E-02; Z-score:1.65E+00

Methylation in Case

3.90E-01 (Median) Methylation in Control 3.30E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC7A10 in lung adenocarcinoma [ 9 ]

Location

Body (cg18031850)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.79E+00 Statistic Test p-value:3.72E-03; Z-score:2.78E+00

Methylation in Case

3.36E-01 (Median) Methylation in Control 1.88E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC7A10 in lung adenocarcinoma [ 9 ]

Location

Body (cg25543755)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.17E+00 Statistic Test p-value:7.07E-03; Z-score:1.58E+00

Methylation in Case

6.79E-01 (Median) Methylation in Control 5.82E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Panic disorder

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in panic disorder [ 10 ]

Location

TSS1500 (cg23331484)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-8.48E-01 Statistic Test p-value:1.09E-03; Z-score:-4.71E-01

Methylation in Case

-1.87E+00 (Median) Methylation in Control -1.58E+00 (Median)

Studied Phenotype

Panic disorder[ ICD-11:6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in panic disorder [ 10 ]

Location

Body (cg09968457)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.13E+00 Statistic Test p-value:1.21E-02; Z-score:-5.76E-01

Methylation in Case

1.91E+00 (Median) Methylation in Control 2.16E+00 (Median)

Studied Phenotype

Panic disorder[ ICD-11:6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in panic disorder [ 10 ]

Location

Body (cg04305036)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.06E+00 Statistic Test p-value:3.38E-02; Z-score:2.27E-01

Methylation in Case

1.14E+00 (Median) Methylation in Control 1.07E+00 (Median)

Studied Phenotype

Panic disorder[ ICD-11:6B01]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in papillary thyroid cancer [ 11 ]

Location

TSS1500 (cg23331484)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.27E+00 Statistic Test p-value:1.19E-02; Z-score:5.06E-01

Methylation in Case

1.75E-01 (Median) Methylation in Control 1.38E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in papillary thyroid cancer [ 11 ]

Location

Body (cg05976074)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.09E+00 Statistic Test p-value:9.26E-03; Z-score:4.96E-01

Methylation in Case

2.68E-01 (Median) Methylation in Control 2.45E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in papillary thyroid cancer [ 11 ]

Location

Body (cg18031850)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.18E+00 Statistic Test p-value:1.03E-02; Z-score:5.91E-01

Methylation in Case

1.58E-01 (Median) Methylation in Control 1.34E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumor

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in atypical teratoid rhabdoid tumor [ 12 ]

Location

Body (cg03049846)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.51E+00 Statistic Test p-value:2.51E-04; Z-score:-7.08E-01

Methylation in Case

8.64E-02 (Median) Methylation in Control 1.31E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in atypical teratoid rhabdoid tumor [ 12 ]

Location

Body (cg04305036)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.05E+00 Statistic Test p-value:6.60E-04; Z-score:7.81E-01

Methylation in Case

8.89E-01 (Median) Methylation in Control 8.44E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in atypical teratoid rhabdoid tumor [ 12 ]

Location

Body (cg05976074)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.14E+00 Statistic Test p-value:2.00E-03; Z-score:6.02E-01

Methylation in Case

1.21E-01 (Median) Methylation in Control 1.06E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in atypical teratoid rhabdoid tumor [ 12 ]

Location

Body (cg09968457)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.08E+00 Statistic Test p-value:1.28E-02; Z-score:-6.66E-01

Methylation in Case

7.26E-01 (Median) Methylation in Control 7.86E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Prostate cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC7A10 in prostate cancer [ 13 ]

Location

Body (cg14331316)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.47E+00 Statistic Test p-value:5.79E-03; Z-score:3.16E+00

Methylation in Case

7.98E-01 (Median) Methylation in Control 5.43E-01 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC7A10 in prostate cancer [ 13 ]

Location

Body (cg24141378)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.04E+00 Statistic Test p-value:1.28E-02; Z-score:2.20E+00

Methylation in Case

9.22E-01 (Median) Methylation in Control 8.85E-01 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC7A10 in prostate cancer [ 13 ]

Location

Body (cg10734665)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.37E+00 Statistic Test p-value:1.86E-02; Z-score:-3.00E+00

Methylation in Case

4.20E-01 (Median) Methylation in Control 5.75E-01 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC7A10 in prostate cancer [ 13 ]

Location

Body (cg02641517)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.10E+00 Statistic Test p-value:4.97E-02; Z-score:5.02E+00

Methylation in Case

8.52E-01 (Median) Methylation in Control 7.75E-01 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples
References
1 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
2 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
3 DNA Methylation Dynamics in Urological Tumors.
4 Genome-wide Scan for Methylation Profiles in Breast Cancer
5 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
6 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
7 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
8 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
9 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
10 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
11 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
12 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
13 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.